DK213290D0 - Treatment of cerebrovascular disorders - Google Patents

Treatment of cerebrovascular disorders

Info

Publication number
DK213290D0
DK213290D0 DK213290A DK213290A DK213290D0 DK 213290 D0 DK213290 D0 DK 213290D0 DK 213290 A DK213290 A DK 213290A DK 213290 A DK213290 A DK 213290A DK 213290 D0 DK213290 D0 DK 213290D0
Authority
DK
Denmark
Prior art keywords
treatment
cerebrovascular disorders
phenylphthalanes
dementia
dimethylamino
Prior art date
Application number
DK213290A
Other languages
Danish (da)
English (en)
Inventor
Yoshiaki Tanaka
Naomi Kobayashi
Tadashi Kurimoto
Yugo Ikeda
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26066379&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK213290(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Priority to DK213290A priority Critical patent/DK213290D0/da
Publication of DK213290D0 publication Critical patent/DK213290D0/da
Priority to IL9896891A priority patent/IL98968A/en
Priority to IE268291A priority patent/IE72160B1/en
Priority to ZA916187A priority patent/ZA916187B/xx
Priority to EP91610063A priority patent/EP0474580B1/de
Priority to CA002049368A priority patent/CA2049368C/en
Priority to NZ239437A priority patent/NZ239437A/en
Priority to DK91610063.9T priority patent/DK0474580T3/da
Priority to DE69104314T priority patent/DE69104314T2/de
Priority to AT91610063T priority patent/ATE112166T1/de
Priority to KR1019910014255A priority patent/KR970002246B1/ko
Priority to AU82594/91A priority patent/AU644204B2/en
Priority to JP3224192A priority patent/JPH085787B2/ja
Priority to US08/001,571 priority patent/US5296507A/en
Priority to SG165594A priority patent/SG165594G/en
Priority to HK21595A priority patent/HK21595A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK213290A 1990-09-06 1990-09-06 Treatment of cerebrovascular disorders DK213290D0 (da)

Priority Applications (16)

Application Number Priority Date Filing Date Title
DK213290A DK213290D0 (da) 1990-09-06 1990-09-06 Treatment of cerebrovascular disorders
IL9896891A IL98968A (en) 1990-09-06 1991-07-25 Pharmaceutical compositions of phenylphthalane derivatives for the treatment of cerebrovascular disorders
IE268291A IE72160B1 (en) 1990-09-06 1991-07-30 Use of 1-[3-(Dimethylamino)Propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders
ZA916187A ZA916187B (en) 1990-09-06 1991-08-06 Treatment of cerebrovascular disorders
AT91610063T ATE112166T1 (de) 1990-09-06 1991-08-16 Verwendung von 1-(3-(dimethylamino)propyl>-1- phenylphthalenen zur behandlung zerebrovaskulärer störungen.
DE69104314T DE69104314T2 (de) 1990-09-06 1991-08-16 Verwendung von 1-[3-(Dimethylamino)propyl]-1-phenylphthalenen zur Behandlung zerebrovaskulärer Störungen.
CA002049368A CA2049368C (en) 1990-09-06 1991-08-16 Treatment of cerebro-vascular disorders
EP91610063A EP0474580B1 (de) 1990-09-06 1991-08-16 Verwendung von 1-[3-(Dimethylamino)propyl]-1-phenylphthalenen zur Behandlung zerebrovaskulärer Störungen
NZ239437A NZ239437A (en) 1990-09-06 1991-08-16 Use of 1-[3-(dimethylamino)propyl]-1-phenylphthalanes to treat dementia and cerebrovasular disorders and for inhibiting platelet aggregation
DK91610063.9T DK0474580T3 (da) 1990-09-06 1991-08-16 Anvendelse af 1-(3-dimethylamino)propyl)-1-phenylphthalener til behandling af cerebrovaskulære sygdomme
KR1019910014255A KR970002246B1 (ko) 1990-09-06 1991-08-19 뇌혈관 장해 치료용 약제조성물
AU82594/91A AU644204B2 (en) 1990-09-06 1991-08-20 Treatment of cerebrovascular disorders
JP3224192A JPH085787B2 (ja) 1990-09-06 1991-09-04 痴呆及び脳血管障害予防・治療剤並びに血小板凝集抑制剤
US08/001,571 US5296507A (en) 1990-09-06 1993-01-06 Treatment of cerbrovascular disorders
SG165594A SG165594G (en) 1990-09-06 1994-11-16 1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders
HK21595A HK21595A (en) 1990-09-06 1995-02-16 Use of 1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK213290A DK213290D0 (da) 1990-09-06 1990-09-06 Treatment of cerebrovascular disorders
SG165594A SG165594G (en) 1990-09-06 1994-11-16 1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders

Publications (1)

Publication Number Publication Date
DK213290D0 true DK213290D0 (da) 1990-09-06

Family

ID=26066379

Family Applications (2)

Application Number Title Priority Date Filing Date
DK213290A DK213290D0 (da) 1990-09-06 1990-09-06 Treatment of cerebrovascular disorders
DK91610063.9T DK0474580T3 (da) 1990-09-06 1991-08-16 Anvendelse af 1-(3-dimethylamino)propyl)-1-phenylphthalener til behandling af cerebrovaskulære sygdomme

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK91610063.9T DK0474580T3 (da) 1990-09-06 1991-08-16 Anvendelse af 1-(3-dimethylamino)propyl)-1-phenylphthalener til behandling af cerebrovaskulære sygdomme

Country Status (14)

Country Link
EP (1) EP0474580B1 (de)
JP (1) JPH085787B2 (de)
KR (1) KR970002246B1 (de)
AT (1) ATE112166T1 (de)
AU (1) AU644204B2 (de)
CA (1) CA2049368C (de)
DE (1) DE69104314T2 (de)
DK (2) DK213290D0 (de)
HK (1) HK21595A (de)
IE (1) IE72160B1 (de)
IL (1) IL98968A (de)
NZ (1) NZ239437A (de)
SG (1) SG165594G (de)
ZA (1) ZA916187B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2148120T3 (es) * 1997-07-08 2002-01-16 Lundbeck & Co As H Metodo para la preparacion de citalopram.
JP4674339B2 (ja) * 1998-08-07 2011-04-20 三菱化学株式会社 脳損傷の予防・治療剤
PL199423B1 (pl) * 1998-10-20 2008-09-30 Lundbeck & Co As H Sposób wytwarzania citalopramu
IL143422A0 (en) 1998-12-23 2002-04-21 Lundbeck & Co As H Method for the preparation of 5-cyanophthalide
DK1173431T4 (da) 1999-04-14 2010-01-04 Lundbeck & Co As H Fremgangsmåde til fremstilling af citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
BG64901B1 (bg) * 2000-05-29 2006-08-31 H. Lundbeck A/S Метод за получаване на циталопрам
CA2354877C (en) 2000-08-18 2006-05-02 H. Lundbeck A/S Method for the preparation of citalopram
WO2001045483A2 (en) * 2000-12-22 2001-06-28 H. Lundbeck A/S Method for the preparation of pure citalopram
BG65515B1 (bg) * 2002-07-26 2008-10-31 H. Lundbeck A/S Метод за получаване на 5-цианофталид
PL1691811T3 (pl) 2003-12-11 2014-12-31 Sunovion Pharmaceuticals Inc Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram
DE102007051090A1 (de) 2007-06-28 2009-01-08 Charité - Universitätsmedizin Berlin SSRI zur Behandlung neuronaler Krankheiten
EP2008653A1 (de) * 2007-06-28 2008-12-31 Charité-Universitätsmedizin Berlin Serotonerge Verbindungen zur Behandlung neuronaler Krankheiten
CN104005415B (zh) * 2014-02-18 2015-12-02 中铁十六局集团北京轨道交通工程建设有限公司 微风化花岗岩中地下连续墙的高效成槽施工方法
CN106871753B (zh) * 2017-01-04 2018-10-16 中铁隧道集团有限公司 一种用于提高水平岩层隧道成型的装药方法

Also Published As

Publication number Publication date
CA2049368A1 (en) 1992-03-07
ZA916187B (en) 1992-04-29
ATE112166T1 (de) 1994-10-15
IL98968A0 (en) 1992-07-15
JPH085787B2 (ja) 1996-01-24
DE69104314D1 (de) 1994-11-03
EP0474580A2 (de) 1992-03-11
DE69104314T2 (de) 1995-02-16
EP0474580A3 (en) 1992-06-03
IL98968A (en) 1996-06-18
IE72160B1 (en) 1997-03-26
SG165594G (en) 1995-05-12
CA2049368C (en) 2001-10-23
KR920005983A (ko) 1992-04-27
EP0474580B1 (de) 1994-09-28
DK0474580T3 (da) 1995-04-03
HK21595A (en) 1995-02-24
KR970002246B1 (ko) 1997-02-26
AU8259491A (en) 1992-03-12
NZ239437A (en) 1997-02-24
IE912682A1 (en) 1992-03-11
AU644204B2 (en) 1993-12-02
JPH04244024A (ja) 1992-09-01

Similar Documents

Publication Publication Date Title
DK213290D0 (da) Treatment of cerebrovascular disorders
NO922147D0 (no) Heterocykliske derivater
DK0530505T3 (da) Hydantoinderivater
NO941052L (no) Benzimidazolforbindelser, deres anvendelse og fremstilling
NO933445D0 (no) Heterocyklisk-cykliske amin-derivater
DE69623899D1 (de) Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen
GR3030798T3 (en) 2-(Piperidin-4-yl, pyridin-4-yl and tetrahydropyridin-4-yl)benzofuran-7-ol and carbamate derivatives, their preparation and their use as acetylcholinesterase inhibitors.
DK132188A (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
ATE170852T1 (de) Benzolsulfonamid-derivate zur behandlung der blaseninstabilität
FI935800A0 (fi) Antidepressiva och mot Parkisons sjukdom verksamma foereningar
DE69018726D1 (de) Cumarinderivate, ihre Herstellung und ihre Verwendung zur Behandlung von zerebrovaskulären Störungen.
PT87005A (pt) Process for preparing n-phenethylaminoalkyl-benzamide anti-arrhythmic agents
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
ES8602723A1 (es) Un procedimiento para la preparacion de nuevas n-bencil-propilaminas sustituidas.
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ATE113950T1 (de) 4,5,6,11-tetrahydrobenzo(6,7>-cycloocta(1,2- b>thiophen-6,11-imine und 6,11-dihydrobenzo(6,7>- cycloocta(1,2-b>thiophen-6,11-imine.
DE69327077D1 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
RO95572A2 (ro) Procedeu pentru prepararea unor derivati de 1,3-oxazolidin-2-ona

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment